Form S-3 Zentalis Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Zentalis Pharmaceuticals (ZNTL) Files $250M Mixed Shelf
March 26, 2025 4:20 PM EDTZentalis Pharmaceuticals (NASDAQ: ZNTL) has filed $250,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Purchase Contracts
Units
